Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2001 1
2002 1
2003 2
2005 1
2006 4
2008 1
2009 1
2010 7
2011 7
2012 6
2013 7
2014 4
2015 6
2016 5
2017 5
2018 7
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Stable Coronary Artery Disease: Treatment.
Braun MM, Stevens WA, Barstow CH. Braun MM, et al. Am Fam Physician. 2018 Mar 15;97(6):376-384. Am Fam Physician. 2018. PMID: 29671538 Free article. Review.
Treatment of comorbidities such as diabetes mellitus, hyperlipidemia, and hypertension should be optimized to reduce cardiovascular risk. ...Select patients may benefit from coronary revascularization with percutaneous coronary interve
Treatment of comorbidities such as diabetes mellitus, hyperlipidemia, and hypertension should be optimized to reduce ca …
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.
Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS, Hamza TH, Shah B, Stefanini GG, Sidhu MS, Tanguay JF, Ramanathan K, Sharma SK, French J, Hueb W, Cohen DJ, Fuster V; FREEDOM Follow-On Study Investigators. Farkouh ME, et al. J Am Coll Cardiol. 2019 Feb 19;73(6):629-638. doi: 10.1016/j.jacc.2018.11.001. Epub 2018 Nov 11. J Am Coll Cardiol. 2019. PMID: 30428398 Free PMC article. Clinical Trial.
BACKGROUND: The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for patients with diabetes mellitus (DM) and multivessel coronary
BACKGROUND: The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of …
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. BARI 2D Study Group, et al. N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7. N Engl J Med. 2009. PMID: 19502645 Free PMC article. Clinical Trial.
BACKGROUND: Optimal treatment for patients with both type 2 diabetes mellitus and stable ischemic heart disease has not been established. ...Randomization was stratified according to the choice of percutaneous coronary intervent
BACKGROUND: Optimal treatment for patients with both type 2 diabetes mellitus and stable ischemic heart disea
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
Ramanathan K, Abel JG, Park JE, Fung A, Mathew V, Taylor CM, Mancini GBJ, Gao M, Ding L, Verma S, Humphries KH, Farkouh ME. Ramanathan K, et al. J Am Coll Cardiol. 2017 Dec 19;70(24):2995-3006. doi: 10.1016/j.jacc.2017.10.029. J Am Coll Cardiol. 2017. PMID: 29241487 Free article. Clinical Trial.
BACKGROUND: Randomized trial data support the superiority of coronary artery bypass grafting (CABG) surgery over percutaneous coronary intervention (PCI) in diabetic patients with multivessel coronary artery diseas
BACKGROUND: Randomized trial data support the superiority of coronary artery bypass grafting (CABG) surgery over …
Coronary artery disease and diabetes mellitus.
Aronson D, Edelman ER. Aronson D, et al. Cardiol Clin. 2014 Aug;32(3):439-55. doi: 10.1016/j.ccl.2014.04.001. Epub 2014 Jun 10. Cardiol Clin. 2014. PMID: 25091969 Free PMC article. Review.
For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the s …
For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization proce …
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
Esper RB, Farkouh ME, Ribeiro EE, Hueb W, Domanski M, Hamza TH, Siami FS, Godoy LC, Mathew V, French J, Fuster V. Esper RB, et al. J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2826-2837. doi: 10.1016/j.jacc.2018.09.046. J Am Coll Cardiol. 2018. PMID: 30522646 Free article. Clinical Trial.
BACKGROUND: Diabetes mellitus (DM) is associated with complex coronary artery disease (CAD), which in turn results in increased morbidity and mortality from cardiovascular disease. OBJECTIVES: This study sought to evaluate the utility of …
BACKGROUND: Diabetes mellitus (DM) is associated with complex coronary artery disease (CAD), which in tur …
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
Farkouh ME, Sidhu MS, Brooks MM, Vlachos H, Boden WE, Frye RL, Hartigan P, Siami FS, Bittner VA, Chaitman BR, Mancini GBJ, Fuster V. Farkouh ME, et al. J Am Coll Cardiol. 2019 Feb 5;73(4):400-411. doi: 10.1016/j.jacc.2018.11.044. J Am Coll Cardiol. 2019. PMID: 30704571 Free article.
BACKGROUND: The optimal coronary revascularization strategy in patients with stable ischemic heart disease (SIHD) who have type 2 diabetes (T2DM) and chronic kidney disease (CKD) remains unclear. ...For patients without CKD, coronary
BACKGROUND: The optimal coronary revascularization strategy in patients with stable ischemic heart disease (SIHD …
Coronary Artery Disease and Diabetes Mellitus.
Aronson D, Edelman ER. Aronson D, et al. Heart Fail Clin. 2016 Jan;12(1):117-33. doi: 10.1016/j.hfc.2015.08.010. Heart Fail Clin. 2016. PMID: 26567979 Review.
For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the s …
For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization proce …
[Percutaneous coronary intervention versus bypass surgery in patients with diabetes and multivessel coronary disease. Coronary revascularization after FREEDOM].
Dörr R, Stumpf J, Dalibor J, Simonis G, Spitzer SG. Dörr R, et al. Herz. 2014 May;39(3):331-42. doi: 10.1007/s00059-014-4089-y. Herz. 2014. PMID: 24740094 German.
Is coronary revascularization required in a patient with chronic stable coronary artery disease or can optimized medical therapy (OMT) alone be a sufficient alternative? ...If similar relevant ischemia can be non-invasively or inva …
Is coronary revascularization required in a patient with chronic stable coronary artery disease or can optimi
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease.
Tsujimoto T, Kajio H. Tsujimoto T, et al. Int J Cardiol. 2018 Dec 15;273:1-7. doi: 10.1016/j.ijcard.2018.07.143. Epub 2018 Aug 2. Int J Cardiol. 2018. PMID: 30082118 Free article. Clinical Trial.
In patients with pulse pressure < 60 mmHg, the risk of MACE was significantly higher in the early revascularization group (HR: 1.37, 95%CI: 1.04-1.81, P = 0.02) and was specifically and significantly higher in the percutaneous coronary intervention group ( …
In patients with pulse pressure < 60 mmHg, the risk of MACE was significantly higher in the early revascularization group (HR: 1.37, 95%C …
69 results
Jump to page
Feedback